ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors.

Lillian L Siu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.